Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association.
Hirsh
J
J
Anand
S S
SS
Halperin
J L
JL
Fuster
V
V
D000925:Anticoagulants / Q000009:adverse effects / Q000266:history / Q000494:pharmacology / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006493:Heparin / Q000009:adverse effects / Q000266:history / Q000494:pharmacology / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology / Q000627:therapeutic use; D049673:History, 20th Century; D006801:Humans; D013921:Thrombocytopenia / Q000139:chemically induced / Q000517:prevention & control; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control; D013927:Thrombosis / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin